Xencor, Inc. (XNCR)
NASDAQ: XNCR · IEX Real-Time Price · USD
18.26
-0.76 (-4.00%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Xencor Market Cap
Xencor has a market cap or net worth of $1.13 billion as of July 2, 2024. Its market cap has decreased by -24.73% in one year.
Market Cap
1.13B
Enterprise Value
678.97M
1-Year Change
-24.73%
Ranking
Category
Stock Price
$18.26
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $1.13B, an increase of 358.83%. That is a compound annual growth rate of 15.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 1.13B | -12.88% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vir Biotechnology | 1.21B |
| Sana Biotechnology | 1.21B |
| Day One Biopharmaceuticals | 1.20B |
| Immatics | 1.20B |
| Spyre Therapeutics | 1.19B |
| Verona Pharma | 1.12B |
| Prothena Corporation | 1.11B |
| AtriCure | 1.10B |